Your data on MRCVSonline
The nature of the services provided by Vision Media means that we might obtain certain information about you.
Please read our Data Protection and Privacy Policy for details.

In addition, (with your consent) some parts of our website may store a 'cookie' in your browser for the purposes of
functionality or performance monitoring.
Click here to manage your settings.
EmailIphone Application    Posted: 18th June 2012
If you would like to forward this story on to a friend, simply fill in the form below and click send.
Your friend's email:
Your email:
Your name:
 
 
Send Cancel
New vaccine formulation for chickens
Tablet formulation of vaccine developed

A tablet formulation of a vaccine has been developed to help protect chickens against Newcastle disease, in low-resource rural areas.

Under the auspices of the Edinburgh-based charity, the Global Alliance for Livestock Veterinary Medicines (GALVmed), the fast-dissolving tablet has been developed by PATH, an international non-profit organisation.

Many of the world's 2.5 billion people who survive on a mere US $2 a day rely on chickens and other poultry for cash in crises, but the main threat to such poultry is Newcastle disease. Furthermore, the conventional vaccine against the disease is packaged in easily damaged glass vials.

The new tablet, however, is more convenient not only to transport, but also store and use in remote rural settings.

Baptiste Dungu, GALVmed's senior director for research and development, said: "GALVmed is proud to support the development of the Newcastle disease vaccine tablet, which may soon make Newcastle disease vaccine cheaper and easier for poor farmers to transport, store and use."

Become a member or log in to add this story to your CPD history

Practices urged to audit neutering data

News Story 1
 RCVS Knowledge has called on vet practices to audit their post-operative neutering outcomes.

It follows the release of the 2024 NASAN benchmarking report, which collates data from neutering procedures performed on dogs, cats and rabbits.

The benchmarking report enables practices in the UK and Ireland to compare their post-operative outcomes to the national average. This includes the rate of patients lost to follow-up, which in 2024 increased to 23 per cent.

Anyone from the practice can submit the data using a free template. The deadline for next report is February 2026.

Visit the RCVS Knowledge website to complete an audit. 

Click here for more...
News Shorts
UK's BSE risk status downgraded

The WOAH has downgraded the UK's international risk status for BSE to 'negligible'.

Defra says that the UK's improved risk status recognises the reputation for having the highest standards for biosecurity. It adds that it demonstrates decades of rigorous animal control.

Outbreaks of Bovine Spongiform Encephalopathy, also known as mad cow disease, have previously resulted in bans on Britain's beef exports.

The UK's new status could lead to expanded trade and better confidence in British beef.

Christine Middlemiss, the UK's chief veterinary officer, said: "WOAH's recognition of the UK as negligible risk for BSE is a significant milestone and is a testament to the UK's strong biosecurity measures and the hard work and vigilance of farmers and livestock keepers across the country who have all played their part in managing the spread of this disease.